Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Robert K. who wrote (5257)	1/6/1998 9:05:00 PM
From: aknahow	Read Replies (2) \| Respond to of 17367

IMPORTANT!!! XOMA confirms it is P III trials for trauma. Web site under Compay Inormation the new Fact Sheet indicates they are in P III trials, with 1650 subjects to be accumulated. Bob, realize you were waiting for this so I hope that you as well as Mr. Market are happy about this development. Don't complain that I fail to get the latest info posted here. What do you think the market will do with this outstanding news? Provablamente se pone con el resto de la caquita, merdita, bosto y b.s. que ya existe en gran cantidad en Wall Street.